The feasibility of using a subcutaneously implanted portal system attached to a conventional J6-gauge 
However, latent and severe respiratory depression has been identified as a problem in patients administered epidural opioid without prior opioid intake. 4 ,5 The incidence of this side-effect appears to be much lower if patients have tolerance to opioids due to prior opioid administration, for example, in cancer pain.
Epidural opioids frequently need to be given at least twice daily and an indwelling catheter is indicated for logistic considerations. The catheter can be brought out percutaneously through the posterior aspect of the mid-lumbar spine as is the case in obstetric or operative patients. However, the catheter would probably need to be repositioned every week or so to minimise the possibility of an epidural infection, ansmg from infection at the skin puncture site.
It has been possible to leave the catheter in situ without evidence of epidural infection for longer periods of time (for up to nine months) by tunnelling the catheter to the anterior chest wall. These patients had the catheter sutured to the skin at its exit point and had two bacterial filters (0.22 micron) connected to the end of the 16-gauge catheter. Patients can become accustomed to wearing this device attached to the anterior chest wall but it does restrict certain daily activities (e.g. washing). (Cherry, Gourlay and Cousins, unpublished data. ) We have investigated means of implanting systems incorporating reservoirs and a gasdriven pump but have found the cost to be prohibitive for routine use.
An alternative concept involving a percutaneous injection portal system should have the following characteristics for widespread clinical use: 1. readily palpable externally, 2. simple to inject with an easily discernible end point, 3. be capable of adapting to a 16-gauge epidural catheter, 4. able to be injected with currently available disposable needles, 5. have a reasonable cost, 6. be able to accommodate opioid solutions of different concentration, and therefore different viscosity. This communication describes the technique of insertion and evaluates the feasibility of use of a subcutaneously implanted portal system (Portacath®, Pharmacia) for the epidural administration of opioid drugs to control cancer pain.
MATERIALS AND METHODS

Insertion of the portal system
The patient was positioned as shown in Figure la and a prominent high lumbar or low thoracic interspace palpated. The more protuberent the space the greater the ease of tunnelling in the procedure. The patient's skin was prepared with Povidone-iodine and draped in a standard surgical fashion.
The skin and subcutaneous tissue were anaesthetised using lignocaine IOJo with adrenalin and a 1.0 cm transverse incision made down to the deep fascia. The epidural needle was inserted through the incision and the epidural space identified by standard technique. 6 The epidural catheter was directed in a cephalad direction and at least 10 cm passed into the epidural space (Figure 1 b) . FIGURE I.-Implantation of the Epidural Portal System la: Position of patient prior to implantation. I b: Insertion of l6-gauge epidural catheter through a Tuohy needle.
The needle was then removed over the epidural catheter, and an area of skin and subcutaneous tissue infiltrated laterally over the thorax approximately 10 cm (one epidural needle length) from the first incision. A 5 mm incision was made at this site and the epidural needle passed through this incision (the second) so that the tip protruded through the first incision ( Figure Ic) .
The catheter was fed in a retrograde fashion through the epidural needle (Figure 1 c) ensuring that the catheter was not knotted. When the catheter was visible at the hub of the epidural needle, both needle and cathether were withdrawn. The catheter was then removed from the second incision site until the catheter was no longer protruding from the first incision (with due care taken not to withdraw the catheter from the epidural space). This procedure sometimes needed to be repeated, depending on the size of the patient, until the catheter had been tunnelled to within 10 cm of the site chosen for the portal implantation at an accessible position over the thoracic cage on the anterolateral aspect of the chest wall.
Following infiltration with local anaesthetic, a 1.0 to 1.5 cm incision was made at a position Id: Portal attached to the inserted epidural catheter. within 10 cm of the site of portal implantation and the catheter tunnelled to this point as previously described ( Figure Id , third incision). Using lignocaine 10,10 with adrenaline, a radial incision (4th incision) was made, large enough to enable the portal to be implanted in a pocket made by blunt dissection. The catheter was then tunnelled to this site and cut, leaving approximately 2 cm protruding from the skin. The catheter was kept visible at the previous incision by passing it over the epidural needle laying transversely under it on the skin.
The catheter was then slid over the stem of the portal for at least 5 mm and tested to ensure that it would not readily dislodge. The portal was then injected with normal saline (2ml) to ensure a watertight fit and that the catheter was not kinked. The portal was then inserted into the prepared subcutaneous pocket. The catheter was now retracted at the 'third' incision site to remove any kin king at the junction of the catheter and stem of the portal. This procedure left approximately 2 to 3 cm of redundant catheter which was placed horizontally in a loop under the fascia through this slightly larger incision ( Figure Id) .
The wounds were then closed in layers. The patients were given an intravenous dose of fluocloxacillin (2g) (or cephradine if the patient was allergic to penicillin) as a once-only dose prior to commencement of the procedure. Cadaver study A portal was implanted on both the left and right anterolateral aspects of the chest wall as illustrated in Figure Id in an adult cadaver. The tip of the epidural catheter that would normally be in the epidural space was inserted into a sterile 1000 ml empty plastic infusion bag. This technique allowed the collection of the injectate that would normally have been deposited in the epidural space. Three hundred injections (2ml of normal saline containing 0.005070 w/v methylene blue) were made through each portal and the injectate collected as described above. Aliquots of the same solution were injected using both needle types, thus minimising any changes in particulate contamination originating from the solution used for injection. The injection technique used in the cadaver was identical to that used in patients which consists of skin preparation with an alcohol swab, palpation and immobilisation of the portal between thumb and index finger while injecting, inserting the needle until contact with the metal back of the portal is made and then injecting. The portal on the left was injected using 25 g x 1 inch disposable needles while the portal on the right was injected using 22 g x 2 inch Huber point needles. The needles were changed after every five injections because of the number of Huber point needles available for the study. The injectate from each needle type was disconnected from the epidural catheter and stored at -15 QC (4 days) until it was processed as follows.
The total injectate collected using either needle type was filtered under vacuum (water pump, approximately 0.5 atmosphere) onto separate 0.22 micron membrane filters (Nucleopore® , contained in a conventional glass holder) which had been moistened with sterile normal saline 1.0 m!. The flow rate was measured by taking the time for 10 ml to be filtered, initially and after 500 ml of injectate had flowed through the filter.
The membrane filters were removed from their holders and photographed macroscopically using incident light illumination and then processed for scanning electron microscopy as follows: the membranes were rapidly frozen by placing them on a cooled metal block maintained at temperature -193 QC by liquid nitrogen. They were then transferred to a freeze-drying apparatus and dried over 36 hours at -39 QC at a pressure of approximately 1 x 10-3 torr over phosporus pentoxide which acted as water vapour absorbent. Specimens were then returned to ambient temperature, and maintained under vacuum for a further six hours for final drying and then returned to atmospheric pressure.
The membranes were then Sputter coated with gold (Polaron Model E5200 coater), examined and photographed in an E.T.E.C. Autoscan scanning electron microscope.
RESUL TS AND DISCUSSION
The implant able portal system described in this communication has been successfully employed in 50 patients for periods ranging up to 36 weeks. It is generally recommended by the FIGURE 2.-Photographs of the injection site in the cadaver following 300 injections using Huber point (Figure 2a ) or disposable needles (Figure 2b ). The Huber point needles used were 22 gauge x 2 inch while the disposable needles used were 25 gauge x I inch. manufacturers of injection portal systems that Huber point needles be used for injection rather than disposable needles to minimise the possibility of blockage of the catheter. The Cadaver study After completion of the 300 injections, the skin injection sites were photographed, the portals were removed and the surrounding subcutaneous fatty tissue examined for staining by methylene blue. There was a greater extent of tissue damage associated with the larger gauge H uber point needles ( Figure 2a ) than with the disposable needles (Figure 2b) . Subjectively, there appeared to be more staining of surrounding tissues when the Huber point needles were used when compared with the disposable needles. However, in either case, the exent of this leakage was considered minor. Therefore, it was concluded that the portal membrane did not exhibit significant leakage following repeated injections using Huber point or disposable needles.
Injectate filtration rates
The initial flow rate of injectate filtered under vacuum was 11.5 sec. for the Huber point needles and 11.0 sec. for the disposable needles. The flow rates measured after 500 ml of injectate had been filtered were 42 sec. and 15 sec. for the Huber point and disposable needles respectively. This result suggested that there was a greater amount of particulate matter associated with the use of Huber point needles.
Light microscopy
The 0.22 micron filters were examined under the light microscope prior to preparation for electron microscopy. The photographs taken under light microscope indicate a greater incidence of large particulate matter when using Huber needles (Figure 3a ) when compared with disposable needles (Figure 3b ). In contrast, there appeared to be material composed of long filaments in the disposable needle injectate which was absent in the injectate obtained from Huber needles.
4. -Scanning electron microscope photomicrographs of particulate matter retained on the 0.22 micron membrane filters. 4a: Filament and particulate contamination from injection using 25-gauge disposable needles (approximate magnification 760x). 4b: Dried and unused alcohol swabs (approximate magnification 760x).
Scanning electron microscopy
Examination of the membranes by scanning electron microscopy reveals the nature of the particulate contamination using the disposable needles (Figure 4) . Figure 4a shows a section from the membrane where both long filaments and particulate matter are present (approximate magnification 760x).
One possible explanation of the source of the filament contamination would be from the alcohol swab as the skin of the cadaver was prepared with a new swab prior to each injection to simulate the clinical situation. A fresh dried alcohol swab was sUbjected to similar preparation prior to scanning electron microscope examination. It is apparent that the nature of the material of the swab is similar to that found on the membrane surface (Figure 4b -same magnification). It is suggested that the swab material is abraded during skin preparation and fine and broken filaments are transported into the reservoir chamber of the portal during injection. We can offer no reason why this occurs only with the disposable needles. Figure 4c shows a higher magnification (approximately 1520x) of the particulate contamination from the membrane used to filter the injectate from the disposable needles. Figure 4d shows a section of the membrane obtained using the Huber point needle of the same magnification (i.e. approximately 1520x). In comparing these two photomicrographs (i.e. Figure 4c and 4d) the nature of the particulate contamination appears similar but is much more dense on the membrane obtained from the Huber point needles. This finding is consistent with the differing rates of filtration after 500 ml of the two injectates had been filtered.
The source of the particulate contamination cannot be accurately identified as the study was conducted in a cadaver. It is concluded that less particulate contamination occurs in the reservoir of the injection portal when 25-gauge disposable needles are used than with 22-gauge Huber point needles. Therefore, we have routinely used disposable needles to inject opioid drugs into the epidural space via the portal for the treatment of severe pain in cancer patients. 
Patient study
The implanted epidural portal system has been successfuly employed in fifty patients without serious complications. Seventy per cent of these patients have been managed at home where either the district nurse or a family member has undertaken the two or three times a day (24 hours) injection of epidural opioid via the portal. The remainder of the patients have been managed in a hospice or hospital setting. The portals have remained in situ for up to nine months, but the mean duration of use is 12 weeks. This latter figure of 12 weeks is reduced because of the number of patients dying of their disease rather than a lack of efficacy of the technique (i.e. the portals were not blocked).
Of the initial fifty patients who have had portals inserted as a means of access to the epidural space, five portals have had to be removed from different patients and replaced in only one case (Table 1) . Two patients were diabetic who required epidural portals to manage pain related to cancer. However infection at the portal site occurred at three and five days after insertion. This was a potentially serious complication requiring removal of both portal and catheter and as a result we have discontinued the practice of epidural opioids in diabetic patients. One patient scratched repeatedly at the skin over the catheter requiring the catheter and portal to be removed. There have been no cases of meningitis, and this is reassuring, considering the depleted immunological status which is often seen in such patients.
On no occasion has the catheter dislodged from the stem of the portal which indicates that this simple means of joining catheter and portal is effective. On eight occasions the portal appeared to be blocked even after attempts at forced flushing with normal saline. On two occasions, the stem of the portal was blocked with material originating from the membrane as a result of needle puncture and in six patients the epidural catheter was blocked by debris requiring reinsertion of a new catheter. The latter problem has been overcome in patients treated since the completion of this study, by cutting the tip off the epidural catheter so that the material will be flushed into the epidural space. The nature of the material that might cause such a blockage is most likely to be inert and therefore should not cause any problems.
In conclusion, the continuous administration of epidural opioids via a subcutaneously implanted portal system provides excellent long-term pain relief in patients with cancer. The technique has been well accepted by patients and nursing staff and has few complications. The relative efficacy of epidural morphine compared with standard oral regimens in the treatment of severe pain in patients with cancer should be examined in future studies.
